Relative Bioavailability of Dabigatran After Single Oral Administration of Five Different Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects (an Open-label, Randomised, Single-dose, Six-period, Five-sequence Crossover Study)
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Dabigatran etexilate (Primary) ; Dabigatran etexilate
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 14 Jun 2016 Status changed from active, no longer recruiting to completed.
- 31 May 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.
- 31 May 2016 Planned primary completion date changed from 1 May 2016 to 1 Jun 2016.